Central Nervous System Biomarkers Market Substantial Rise in Industrial Sectors to Offer Growth Prospects by 2026
Biomarkers
are measurable indicators used to evaluate and determine
pathogenic processes and therapeutic interventions and predict
treatment response. Biomarkers are used in various scientific fields.
Biomarkers are utilized in drug development and regulatory
decision-making process as they have the potential to improve the
efficiency of drug discovery and development process. Biomarkers
offer information about a patient at virtually every stage of care.
Biomarker development for brain disorders is increasing rapidly with
advanced technologies that permit molecular and functional disease
measures taken from brain, cerebrospinal fluid (CSF), and plasma.
Central Nervous System Biomarkers Market –
Regional Analysis
On the basis of region, the global central nervous
system biomarkers market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa.
North America central nervous system biomarkers
market is expected to show significant growth, owing to expansion
activities by key players in the region. For Instance, in January
2017, bioMérieux, an in vitro diagnostics company, entered into a
partnership with Banyan Biomarkers. Banyan Biomarkers develops,
validate, and market blood-based biomarkers for traumatic brain
injury. Under this agreement, bioMérieux took an equity
participation of around US$ 7 million in Banyan Biomarkers and also
obtained rights to develop market for Banyan’s proprietary tests
worldwide.
Increasing prevalence of Alzheimer’s disease is
expected to drive growth for the central nervous system biomarkers
market in Asia Pacific. For instance, according to Alzheimer's
Disease International (ADI), in 2015, around 23 million people in
Asia Pacific suffered from dementia.
Keys players
Thermo fisher scientific, Enzo Biochem Inc.,
Abiant Inc., EKF Diagnostics Holdings Inc., Abastar MDX Inc., Acumen
Pharmaceuticals Inc., Adlyfe Inc., Apitope International, Alseres
Pharmaceuticals Inc., Aposense, Banyan Biomarkers, Avid
Radiopharmaceuticals Inc., Diagenic ASA, Avacta Group plc., Applied
Neurosolutions Inc., Merc & Co. Inc., and Exonhit Therapeutics.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/2434
Central Nervous System Biomarkers Market –
Taxonomy
By Application
• Drug Discovery & Development
• Personalized Medicines
• Disease Risk Assessment
• Diagnostics
By Disease Indication
• Alzheimer’s Disease
• Multiple Sclerosis
• Parkinson’s Disease
• Traumatic Brain Injury
• Other Neurological Conditions
By End User
• Diagnostic Labs
• Clinics/Hospitals
• Research Centers
By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
About Coherent Market Insights
Central Nervous System Biomarkers Market,Central Nervous System Biomarkers trends,Central Nervous System Biomarkers growth,Central Nervous System Biomarkers insights,Central Nervous System Biomarkers outlook
Coherent Market Insights is a prominent market
research and consulting firm offering action-ready syndicated
research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments
Post a Comment